Arena Pharmaceuticals Inc (NASDAQ:ARNA) - Overview

Stock Report

Arena Pharmaceuticals Inc ARNA

Last Price
$1.41

Day Change
0.01|0.71%

As of 02/12/2016
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close1.40
Day Range1.37 - 1.46
Mkt Cap343.10Mil
52-Wk Range1.30 - 2.32
Yield %-
ISINUS0400471027
Volume2,936,708
P/E-3.71
P/S7.39
P/CF-4.37

Share Price

Financials
201320142015
More ...
Income Statement
Revenue81.3936.9738.33
Operating Income-22.94-105.27-103.20
Net Income-19.44-60.51-107.98
Basic EPS-0.09-0.28-0.45
Avg. Diluted Shares Outstanding218220241
Balance Sheet
Current Assets248.81181.90174.84
Non Current Assets91.0094.4981.95
Total Assets339.81276.39256.79
Current Liabilities70.7467.3649.90
Total Liabilities247.95229.04203.25
Total Equity91.8647.3553.54
Cash Flow
Operating Cash Flow72.80-101.40-98.11
Capital Expenditure-9.16-8.91-10.99
Free Cash Flow63.64-110.30-109.11

In millions, except "Basic EPS". Currency is USD.

Company Profile

Arena Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

228
Key Stats
More ...
Price/Earning TTM-3.68
Price/Book102.19
Price/Sales TTM9.38
Rev Growth (3 year avg)11.58
EPS Growth (3 year avg)-
Operating Margin % TTM-269.26
Net Margin % TTM-281.74
ROE TTM-214.06
Debt/Equity1.22
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.